Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06265103 · ClinicalTrials.gov registry record
Epilepsy Learning Healthcare System (ELHS)
A clinical trial of Epilepsy and Neurologic Disorder, sponsored by Epilepsy Foundation of America.
- Recruiting
- Registry status
- 100,000
- Enrollment target
- 13
- Study locations
NCT06265103: Recruiting study of Epilepsy and Neurologic Disorder, sponsored by Epilepsy Foundation of America.
NCT06265103 is a study of Epilepsy and Neurologic Disorder that is actively recruiting participants, run by Epilepsy Foundation of America. The registered enrollment target is 100,000 participants, above the 328-participant average among 160 other Epilepsy trials with a reported enrollment target (30388% higher). The trial reports 13 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06265103, a study of Epilepsy and Neurologic Disorder, is actively recruiting participants, sponsored by Epilepsy Foundation of America.
- RECRUITING
- Registry status
- 100,000 participants
- Enrollment target
- 13
- Study locations
Study Summary
The Epilepsy Learning Health System (ELHS) is a quality improvement and research network to improve outcomes for people with epilepsy. The ELHS is designed as a model of value-based chronic care for epilepsy as envisioned by the National Academies of Medicine Committee in their landmark reports "The Learning Health System" and "Epilepsy Across the Spectrum: Promoting Health and Understanding". The ELHS network is a collaboration among clinicians, patients and researchers that promotes the use of data for multiple purposes including one-on-one clinical care, population management, quality improvement and research. The ELHS Registry includes data on children and adults with epilepsy collected during the process of standard epilepsy care. These data are used to create population health reports and to track changes in outcomes over time. ELHS teams use quality improvement methods, such as Plan-Do-Study-Act (PDSA) cycles, to continuously learn how to improve care.
Primary Outcome
\*Seizure frequency: A record of the number of seizures gathered from patient records, journal, or calendar OR the average or typical recent seizure frequency, often expressed as the average daily, weekly, or monthly seizure frequency since the last visit.
Conditions Studied
Interventions
- OTHER Clinical care and quality improvement
Study Locations (13)
Ohio
- Akron Children's Hospital - Akron
- Cincinnati Children's Hospital Comprehensive Epilepsy Center (CCHMC) - Cincinnati
- University of Cincinnati Gardner Neuroscience Institute Epilepsy Center - Cincinnati
California
- Children's Hospital Los Angeles - Los Angeles
- University of Southern California - Los Angeles
Massachusetts
- Partners - Massachusetts General Hospital Epilepsy Service (MGH)/ Partners - Brigham and Women's (BWH) - Boston
- Brigham & Women's Hospital - Boston
Pennsylvania
- Penn State Hershey - Hershey
- Children's Hospital of Philadelphia (CHOP) - Philadelphia
Arizona
- Barrow Neurological Institute Comprehensive Epilepsy Center - Phoenix
Colorado
- UC Health University of Colorado Anshutz - Aurora
Maryland
- Epilepsy Foundation - Bowie
Texas
- UT Southwestern Children's Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100,000 participants |
| Start Date | 2019-03-20 |
| Est. Completion | 2099-02-14 |
What NCT06265103 shows while recruiting
NCT06265103 is an observational study that tracks outcomes without assigning an intervention. Its 100,000 participants enrollment target places it among the larger protocols in the corpus, above the 328-participant average among 160 other Epilepsy trials with a reported enrollment target (30388% higher).
The record links to 4 conditions, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Clinical care and quality improvement is the first listed.
NCT06265103 lists 13 locations in 8 states (Ohio, California, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT06265103 about?
NCT06265103 is a clinical study titled "Epilepsy Learning Healthcare System (ELHS)". The Epilepsy Learning Health System (ELHS) is a quality improvement and research network to improve outcomes for people with epilepsy. The ELHS is designed as a model of value-based chronic care for epilepsy as envisioned by the National Academies of Medicine Committee in their landmark reports "The...
What is the current status of trial NCT06265103?
This trial is currently recruiting. The enrollment target is 100,000 participants. The study started on 2019-03-20. Estimated completion is 2099-02-14.
What conditions does trial NCT06265103 study?
This clinical trial studies the following conditions: Epilepsy, Neurologic Disorder, Rare Diseases, Seizure Disorder.
What interventions are being tested in trial NCT06265103?
The interventions under investigation include: Clinical care and quality improvement (OTHER).
Who is sponsoring clinical trial NCT06265103?
This trial is sponsored by Epilepsy Foundation of America, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06265103 being conducted?
This trial has 13 study locations across Arizona, California, Colorado, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06265103's enrollment target sits among peer trials
100,000 1st of 160 higher than 160 of 160 other Epilepsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
RECRUITING
-
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
RECRUITING
-
SeizEAR Safety Study
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Tumor Related Epilepsy
RECRUITING
-
Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02620852 · 100,000 participants · NA
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- NCT03277365 · 100,000 participants · NA
MyGeneRank: A Digital Platform for Next-Generation Genetic Studies
- NCT04281823 · 100,000 participants
DeBakey Cardiovascular Magnetic Resonance Study
- NCT04869111 · 100,000 participants · NA
The BrainHealth Project
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI